Deltex Financial Statements From 2010 to 2026
| DTXMF Stock | USD 0.1 0.00 0.00% |
Check Deltex Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Deltex Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Deltex financial statements analysis is a perfect complement when working with Deltex Medical Valuation or Volatility modules.
Deltex |
Deltex Medical Group Company Operating Margin Analysis
Deltex Medical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Deltex Medical Operating Margin | (0.39) % |
Most of Deltex Medical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deltex Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Deltex Medical Group has an Operating Margin of -0.3945%. This is 98.88% lower than that of the Healthcare sector and 99.0% lower than that of the Medical Devices industry. The operating margin for all United States stocks is 92.84% lower than that of the firm.
Deltex Medical Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Deltex Medical's current stock value. Our valuation model uses many indicators to compare Deltex Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Deltex Medical competition to find correlations between indicators driving Deltex Medical's intrinsic value. More Info.Deltex Medical Group is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Deltex Medical's earnings, one of the primary drivers of an investment's value.About Deltex Medical Financial Statements
Deltex Medical stakeholders use historical fundamental indicators, such as Deltex Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Deltex Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Deltex Medical's assets and liabilities are reflected in the revenues and expenses on Deltex Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Deltex Medical Group. Please read more on our technical analysis and fundamental analysis pages.
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom. Deltex Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 46 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Deltex Pink Sheet
Deltex Medical financial ratios help investors to determine whether Deltex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deltex with respect to the benefits of owning Deltex Medical security.